Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trial

被引：0
作者：
Aung Myat
Simon R. Redwood
Satpal Arri
Bernard J. Gersh
Deepak L. Bhatt
Michael S. Marber
机构：
[1] St Thomas’ Hospital,King’s College London British Heart Foundation Centre of Research Excellence, The Rayne Institute, Cardiovascular Division
[2] Frimley Park Hospital,Department of Cardiovascular Medicine
[3] Frimley Health NHS Foundation Trust,undefined
[4] Mayo Clinic College of Medicine,undefined
[5] Brigham and Women’s Hospital Heart & Vascular Centre and Harvard Medical School,undefined
来源：
Diabetology & Metabolic Syndrome | / 13卷
关键词：
Liraglutide; Glucagon-like peptide-1 receptor agonist; Myocardial ischaemia; Chronic stable angina; Coronary artery disease; Incretin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A Randomized, Double-Blind, Placebo-Controlled Trial of Spironolactone on Carotid Intima-Media Thickness in Nondiabetic Hemodialysis Patients
    Vukusich, Antonio
    Kunstmann, Sonia
    Varela, Cristian
    Gainza, Daniela
    Bravo, Sebastian
    Sepulveda, Daniela
    Cavada, Gabriel
    Michea, Luis
    Marusic, Elisa T.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (08): : 1380 - 1387
  • [42] Liraglutide Augments Weight Loss After Laparoscopic Sleeve Gastrectomy: a Randomised, Double-Blind, Placebo-Control Study
    Thakur, Uttam
    Bhansali, Anil
    Gupta, Rajesh
    Rastogi, Ashu
    OBESITY SURGERY, 2021, 31 (01) : 84 - 92
  • [43] Liraglutide Augments Weight Loss After Laparoscopic Sleeve Gastrectomy: a Randomised, Double-Blind, Placebo-Control Study
    Uttam Thakur
    Anil Bhansali
    Rajesh Gupta
    Ashu Rastogi
    Obesity Surgery, 2021, 31 : 84 - 92
  • [44] A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial
    Kastrup, Jens
    Jorgensen, Erik
    Fuchs, Shmuel
    Nikol, Sigrid
    Botker, Hans Erik
    Gyoengyoesi, Mariann
    Glogar, Dietmar
    Kornowski, Ran
    EUROINTERVENTION, 2011, 6 (07) : 813 - 818
  • [45] Effect of nitrate supplementation on hepatic blood flow and glucose homeostasis: a double-blind, placebo-controlled, randomized control trial
    Shepherd, Anthony I.
    Wilkerson, Daryl P.
    Fulford, Jon
    Winyard, Paul G.
    Benjamin, Nigel
    Shore, Angela C.
    Gilchrist, Mark
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2016, 311 (03): : G356 - G364
  • [46] Supplementation of the Pure Flavonoids Epicatechin and Quercetin Affects Some Biomarkers of Endothelial Dysfunction and Inflammation in (Pre)Hypertensive Adults: A Randomized Double-Blind, Placebo-Controlled, Crossover Trial
    Dower, James I.
    Geleijnse, Johanna M.
    Gijsbers, Lieke
    Schalkwijk, Casper
    Kromhout, Daan
    Hollman, Peter C.
    JOURNAL OF NUTRITION, 2015, 145 (07) : 1459 - 1463
  • [47] A randomized, double-blind, crossover, placebo-controlled trial of 6 weeks benfotiamine treatment on postprandial vascular function and variables of autonomic nerve function in Type 2 diabetes
    Stirban, A.
    Pop, A.
    Tschoepe, D.
    DIABETIC MEDICINE, 2013, 30 (10) : 1204 - 1208
  • [48] Trimetazidine offers myocardial protection in elderly coronary artery disease patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial
    Dai, Zhong-Liang
    Song, Yi-Feng
    Tian, Ya
    Li, Yin
    Lin, Miao
    Lin, Juan
    Wang, Qi
    Wang, Ping
    Gao, Wen-Li
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [49] Trimetazidine offers myocardial protection in elderly coronary artery disease patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial
    Zhong-Liang Dai
    Yi-Feng Song
    Ya Tian
    Yin Li
    Miao Lin
    Juan Lin
    Qi Wang
    Ping Wang
    Wen-Li Gao
    BMC Cardiovascular Disorders, 21
  • [50] Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
    Viney, Nicholas J.
    van Capelleveen, Julian C.
    Geary, Richard S.
    Xia, Shuting
    Tami, Joseph A.
    Yu, Rosie Z.
    Marcovina, Santica M.
    Hughes, Steven G.
    Graham, Mark J.
    Crooke, Rosanne M.
    Crooke, Stanley T.
    Witztum, Joseph L.
    Stroes, Erik S.
    Tsimikas, Sotirios
    LANCET, 2016, 388 (10057) : 2239 - 2253
12345